Ramatroban

Ramatroban
Clinical data
Routes of; administration	Oral
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid;
CAS Number	116649-85-5;
PubChem CID	123879;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C21H21FN2O4S
Molar mass	416.46 g/mol
3D model (JSmol)	Interactive image;
	SMILES C1CC2=C(CC1NS(=O)(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4N2CCC(=O)O;

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Ramatroban (INN) is a thromboxane receptor antagonist indicated for the treatment of coronary artery disease.^[1] It has also been used for the treatment of asthma.^[2]

It was developed by the German pharmaceutical company Bayer AG and is co-marketed in Japan by Bayer and Nippon Shinyaku Co. Ltd. under the tradename Baynas.

References

↑ Fiedler VB, Seuter F, Perzborn E (1990). "Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease". Stroke. 21 (12 Suppl): IV149–51. PMID 2260140. Unknown parameter |month= ignored (help)
↑ Endo S, Akiyama K (1996). "[Thromboxane A2 receptor antagonist in asthma therapy]". Nippon Rinsho (in Japanese). 54 (11): 3045–8. PMID 8950952. Unknown parameter |month= ignored (help)

Template:Ja icon Baynas

Template:Asthma and copd rx

Template:WH Template:WS

[pmid2260140-1] Fiedler VB, Seuter F, Perzborn E (1990). "Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease". Stroke. 21 (12 Suppl): IV149–51. PMID 2260140. Unknown parameter |month= ignored (help)

[pmid8950952-2] Endo S, Akiyama K (1996). "[Thromboxane A2 receptor antagonist in asthma therapy]". Nippon Rinsho (in Japanese). 54 (11): 3045–8. PMID 8950952. Unknown parameter |month= ignored (help)

[1]

[2]

Clinical data

Routes of administration	Oral
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid
CAS Number	116649-85-5
PubChem CID	123879
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₁H₂₁FN₂O₄S
Molar mass	416.46 g/mol
3D model (JSmol)	Interactive image
SMILES C1CC2=C(CC1NS(=O)(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4N2CCC(=O)O

Ramatroban

References

Navigation menu